Pages that link to "Q30396642"
Jump to navigation
Jump to search
The following pages link to Development of adenoviral vector-based mucosal vaccine against influenza (Q30396642):
Displaying 17 items.
- H5N1 vaccines in humans (Q27000896) (← links)
- Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines (Q27013568) (← links)
- Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotides (Q34258568) (← links)
- Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro (Q34287714) (← links)
- Mucosal vaccination with recombinant adenovirus encoding nucleoprotein provides potent protection against influenza virus infection (Q35005641) (← links)
- Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs. (Q36378581) (← links)
- Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses (Q37560829) (← links)
- Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a (Q37722981) (← links)
- Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection. (Q37742680) (← links)
- Recombinant influenza vaccines. (Q38076422) (← links)
- Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials. (Q38096490) (← links)
- Adenovirus-based vaccines against avian-origin H5N1 influenza viruses. (Q38283820) (← links)
- Progress on adenovirus-vectored universal influenza vaccines (Q38421971) (← links)
- DNA-based influenza vaccines as immunoprophylactic agents toward universality (Q38670879) (← links)
- Enhancement of nasal HIV vaccination with adenoviral vector-based nanocomplexes using mucoadhesive and DC-targeting adjuvants (Q38999003) (← links)
- Induction of mucosal immunity by intranasal immunization with recombinant adenovirus expressing major epitopes of Porcine circovirus-2 capsid protein (Q45179251) (← links)
- Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection (Q64374628) (← links)